These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11178412)

  • 21. Polyclonal and monoclonal antibodies as reagents in biochemical and in clinical-chemical analysis.
    Falkenberg FW; Pierard D; Mai U; Kantwerk G
    J Clin Chem Clin Biochem; 1984 Dec; 22(12):867-82. PubMed ID: 6527103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T; Kato K; Shiku H; Yamada K
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.
    Gibson SE; Hsi ED
    Hum Pathol; 2009 May; 40(5):653-61. PubMed ID: 19144386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
    Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells.
    Chen C; Johnston TD; Reddy KS; Merrick JC; Mastrangelo M; Ranjan D
    J Surg Res; 2001 Oct; 100(2):166-70. PubMed ID: 11592787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
    Ohlin M; Sundqvist VA; Gilljam G; Rudén U; Gombert FO; Wahren B; Borrebaeck CA
    Clin Exp Immunol; 1991 Jun; 84(3):508-14. PubMed ID: 1710548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
    Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P
    J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of the human monoclonal antibodies.
    Lindl T
    ALTEX; 1995; 12(1):13-23. PubMed ID: 11178412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of human monoclonal antibodies. Current status and future development].
    Gebauer W; Lindl T
    Arzneimittelforschung; 1989 Feb; 39(2):287-91. PubMed ID: 2659004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of human monoclonal antibodies: A review.
    Lindl T
    Cytotechnology; 1996 Jan; 21(3):183-93. PubMed ID: 22358750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization. Characterization and epitope mapping.
    Ohlin M; Broliden PA; Danielsson L; Wahren B; Rosen J; Jondal M; Borrebaeck CA
    Immunology; 1989 Nov; 68(3):325-31. PubMed ID: 2480328
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.